Analystreport

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) was given a new $13.00 price target on by analysts at Royal Bank of Canada. They now have a "sell" rating on the stock.

Teva Pharmaceutical Industries Limited American Depositary Shares  (TEVA) 
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm Check Earnings Report
US:NYSE Investor Relations: ir.tevapharm.com